These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 23167625

  • 1. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
    Katkoori VR, Manne K, Vital-Reyes VS, Rodríguez-Burford C, Shanmugam C, Sthanam M, Manne U, Chatla C, Abdulkadir SA, Grizzle WE.
    Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

  • 3. EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.
    Kashiwagi E, Shiota M, Yokomizo A, Inokuchi J, Uchiumi T, Naito S.
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):10-7. PubMed ID: 24518515
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 5. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 01; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 6. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
    Yan YX, Li WZ, Huang YQ, Liao WX.
    Prostaglandins Other Lipid Mediat; 2012 Jan 01; 97(1-2):29-35. PubMed ID: 21835258
    [Abstract] [Full Text] [Related]

  • 7. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N, De U, Kang JA, Kim JM, Ahn MY, Lee J, Jung JH, Chung HY, Moon HR, Kim HS.
    Eur J Pharmacol; 2011 May 11; 658(2-3):98-107. PubMed ID: 21376033
    [Abstract] [Full Text] [Related]

  • 8. [Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3].
    Xu S, Zhou WQ, Zhang ZY, Ge JP, Gao JP.
    Zhonghua Nan Ke Xue; 2008 Jun 11; 14(6):489-93. PubMed ID: 18649743
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 10. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK, Narayanan BA, Reddy BS.
    Int J Oncol; 2005 Mar 15; 26(3):785-92. PubMed ID: 15703837
    [Abstract] [Full Text] [Related]

  • 11. Role of leukotriene B4 in celecoxib-mediated anticancer effect.
    Gao P, Guan L, Zheng J.
    Biochem Biophys Res Commun; 2010 Nov 12; 402(2):308-11. PubMed ID: 20937254
    [Abstract] [Full Text] [Related]

  • 12. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK, Park JS, Kim HS, Jun HJ, Kim GE, Suh CO, Yun YS, Pyo H.
    Cancer Res; 2005 Oct 15; 65(20):9501-9. PubMed ID: 16230415
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
    Anai S, Tanaka M, Shiverick KT, Kim W, Takada S, Boehlein S, Goodison S, Mizokami A, Rosser CJ.
    J Urol; 2007 May 15; 177(5):1913-7. PubMed ID: 17437847
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
    Saito T, Tamura D, Asano R.
    Oncol Rep; 2014 Apr 15; 31(4):1637-44. PubMed ID: 24503782
    [Abstract] [Full Text] [Related]

  • 15. Methionine inhibits cellular growth dependent on the p53 status of cells.
    Benavides MA, Oelschlager DK, Zhang HG, Stockard CR, Vital-Reyes VS, Katkoori VR, Manne U, Wang W, Bland KI, Grizzle WE.
    Am J Surg; 2007 Feb 15; 193(2):274-83. PubMed ID: 17236862
    [Abstract] [Full Text] [Related]

  • 16. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 15; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P.
    Breast Cancer Res; 2005 Dec 15; 7(4):R422-35. PubMed ID: 15987447
    [Abstract] [Full Text] [Related]

  • 18. Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.
    Song YC, Kim SH, Juhnn YS, Song YS.
    Ann N Y Acad Sci; 2007 Jan 15; 1095():26-34. PubMed ID: 17404014
    [Abstract] [Full Text] [Related]

  • 19. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE, Jeon NK, Kim J, Lee EJ.
    Ann N Y Acad Sci; 2007 Jan 15; 1095():99-112. PubMed ID: 17404023
    [Abstract] [Full Text] [Related]

  • 20. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms].
    Liu JP, Wei HB, Zheng ZH, Guo WP, Fang JF.
    Yao Xue Xue Bao; 2009 Dec 15; 44(12):1353-8. PubMed ID: 21351468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.